Related Experiment Videos
A re-evaluation of antibiotic sterilisation of heart valve allografts
Thorax
|December 1, 1977
Abstract:
Six different mixtures of antibiotics used for treating heart valve allografts at the National Heart Hospital have been compared and the formulation of the medium in current use is described. The abilities of antibiotic-resistant bacteria, and of fungi with low sensitivities to antifungal agents, to survive treatment are also described. These abilities emphasise the need for routine microbiological screening of every valve.
Insights
Antibiotic treatments for heart valve allografts were compared, revealing that some resistant bacteria and fungi can survive. Routine microbiological screening of all valves is essential to prevent infections.
Area of Science:
- Cardiovascular Surgery
- Infectious Diseases
- Microbiology
Background:
- Heart valve allografts require antibiotic treatment to prevent infection.
- The National Heart Hospital utilizes specific antibiotic mixtures for allograft treatment.
- Understanding microbial resistance is crucial for effective prophylaxis.
Purpose of the Study:
- To compare the efficacy of six different antibiotic mixtures for treating heart valve allografts.
- To describe the formulation of the currently used treatment medium.
- To assess the survival rates of antibiotic-resistant bacteria and fungi post-treatment.
Main Methods:
- Comparative analysis of six distinct antibiotic mixtures.
- Description of the standard treatment medium formulation.
- Microbiological assessment of microbial survival after antibiotic exposure.
Main Results:
- Varied efficacy observed among the six antibiotic mixtures.
- Identification of specific antibiotic-resistant bacterial strains capable of survival.
- Detection of fungal species with reduced sensitivity to antifungal agents post-treatment.
Conclusions:
- The current antibiotic regimens may not be fully effective against all resistant microbes.
- Routine microbiological screening of all heart valve allografts is necessary.
- Enhanced strategies are needed to ensure the sterility of allografts.